Hasan Tahir

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Topics

Venous Thromboembolism

Rheumatoid Arthritis

Anti Inflammatory Drugs

Cardiovascular Disease

Top Venues

Expert opinion on pharmacotherapy

Rheumatology and therapy

European journal of rheumatology

Expert opinion on drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Ameen Jubber, Hasan Tahir, Arumugam Moorthy
Clinical efficacy of JAK inhibitors on enthesitis in spondyloarthropathy: A scoping literature review. Musculoskeletal care (2023)
Ameen Jubber, Jonathan Woodward, Hasan Tahir, Arumugam Moorthy
Venous thromboembolism risk with Janus kinase inhibitors: Is it a class wide effect? Expert opinion on drug safety 21 (8) (2022)
Omar Ahmed, Vinodh Krishnamurthy, Riyaz A Kaba, Hasan Tahir
The management of cardiovascular disease risk in patients with rheumatoid arthritis. Expert opinion on pharmacotherapy 23 (8) (2022)
Benjamin Bennett, Hasan Tahir, Sujata Ganguly, Arumugam Moorthy
An update on the considerations for patients with rheumatic disease being treated with rituximab during the COVID-19 pandemic and the potential drug treatment strategies. Expert opinion on pharmacotherapy 23 (15) (2022)
Swetha Byravan, Armin Fardanesh, Hasan Tahir, Arumugam Moorthy
Emerging COVID-19 vaccines: A rheumatology perspective. International journal of rheumatic diseases 24 (2) (2021)
Hasan Tahir, Swetha Byravan, Armin Fardanesh, Arumugam Moorthy
Promising Treatment Options for Axial Spondyloarthritis: An Overview of Experimental Pharmacological Agents. Journal of experimental pharmacology 13 (2021)
Charles Raine, Benjamin Canning, Jonathan Lewis Marks, Simon Donnelly, Voon H Ong, Hasan Tahir
Severe gangrene in a patient with anti-RNP positive limited cutaneous systemic sclerosis/rheumatoid arthritis overlap syndrome caused by vasculopathy and vasculitis. European journal of rheumatology 5 (4) (2018)
Hasan Tahir, Atul Deodhar, Mark Genovese, Tsutomu Takeuchi, Jacob Aelion, Filip Van den Bosch, Sibylle Haemmerle, Hanno B Richards
Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 Study. Rheumatology and therapy 4 (2) (2017)